Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz

, By Techcrunch
Converge Bio raises M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Apple

Share via:


Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising cost. More than 200 startups are now competing to weave AI directly into research workflows, attracting growing interest from investors. Converge Bio is the latest company to ride that shift, securing new capital as competition in the AI-driven drug discovery space heats up.

The Boston- and Tel Aviv–based startup, which helps pharma and biotech companies…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News
Google rolls out January 2026 Android 16 update: Eligible Pixel devices and what’s fixed
Next News
3 Millionaire-Maker Technology Stocks Worth a Look as the Next Tech Cycle Accelerates
Techcrunch

Popular

More Like this

Load more

Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz

, Published By Techcrunch
Converge Bio raises M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Apple


Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising cost. More than 200 startups are now competing to weave AI directly into research workflows, attracting growing interest from investors. Converge Bio is the latest company to ride that shift, securing new capital as competition in the AI-driven drug discovery space heats up.

The Boston- and Tel Aviv–based startup, which helps pharma and biotech companies…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

Previous News
Google rolls out January 2026 Android 16 update: Eligible Pixel devices and what’s fixed
Next News
3 Millionaire-Maker Technology Stocks Worth a Look as the Next Tech Cycle Accelerates
Techcrunch

More like this

Asus SFF-ready RTX 5070 falls below MSRP — deal...

Hardware Tom’s Hardware -
Components for small form factor PCs often come at...

How to watch Newcastle vs Man City: free streams...

Consumer Service Tom’s Guide -
The EFL Cup 2025/26 semi-final legs will kick off...

Anthropic Invests $1.5 Million in the Python Software Foundation...

Community Slashdot -
Python Software Foundation: We are thrilled to announce...
Load more

Popular

Block title

iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv subscription iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv

Startup Events

Trending News

About

Partnership

Contact us

© 2026 StartupNews.fyi | DOTFYI Media Ventures Private Limited. All Rights Reserved.